Gastro-intestinal dysmotility Digestive System
Conditions
Interventions
Potential participants will be invited into the study by invitation letter with an opt-in reply. Those interested will be given a participant information sheet explaining the rationale for the study a
Acceptance and Action Questionnaire (AQII) to assess psychological flexibility
previous psychology input, QOL: Short form 36 (SF36) Medical: gastrointestinal/HPN complications, HPN requirements, hospital readmissions, length of admissions, sick days, opioid use, and anti-depress
Sponsors
Northern Care Alliance NHS Foundation Trust
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: 1. Has a diagnosis of GID 2. Age 18 years or above 3. Is fluent in English
Exclusion criteria
Exclusion criteria: 1. Insufficiently well to give consent or to take part 2. Currently receiving or due to start psychological therapy at another service or privately 3. Difficulties such that they are currently in receipt of ongoing input from secondary care mental health services 4. Substantial substance abuse difficulties 5. Severe and/or chronic mental health problems such as personality disorders where the interpersonal difficulties themselves are the required focus of an intervention 6. A learning disability, at such a level that specialist skills would be required to deliver an intervention
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Anxiety is measured using the Generalised Anxiety Disorder (GAD7) questionnaire at baseline, week 7 and week 15 2. Depression is measured using the Patient Health Questionnaire (PHQ9) at baseline, week 7 and week 15 3. Psychological flexibility is measured using the Acceptance and Action Questionnaire (AQII) at baseline, week 7 and week 15 4. Health-related quality of life (HRQoL) is measured using the RAND 36-item Health Survey 1.0 (SF-36) at baseline, week 7 and week 15 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Demographics (age, sex, marital status, ethnicity, employment, diagnosis, duration of diagnosis and previous psychology input) are measured using a questionnaire at baseline 2. Medical outcomes (gastrointestinal/HPN complications, HPN requirements, hospital readmissions, opioid use, anti-depressant use) are measured using access to medical records at baseline and week 15 | — |
Countries
England, United Kingdom
Outcome results
None listed